A Republican bill with 13 Republican cosponsors · See all 13 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The ``Second Chance for Moms Act of 2025'' aims to amend existing federal laws regarding mifepristone. It would require a specific warning label on mifepristone stating that its effects can be counteracted by natural progesterone to increase fetal survival. The bill also directs the Secretary to establish or maintain a 24/7 toll-free hotline for women seeking to reverse the effects of the drug. Under this bill, hotline referrals are limited exclusively to health care providers that offer abortion pill reversal services.
Yes
No question was scored yes.
The opposite
- Scored -5
Does this make abortion easier to get?
The bill mandates a warning label and restricts hotline referrals to specific abortion pill reversal providers, which may create barriers to medication abortion access.
- Scored -4
Would women be better off under this?
The bill imposes new requirements on medication labeling and restricts the scope of medical referrals available to women seeking to reverse mifepristone effects.
- Scored -3
Does this narrow the gap between how men and women are treated?
By regulating the information and support available to women regarding pregnancy and mifepristone, the bill impacts reproductive autonomy.
Who it would affect, and how
Potential Positive Impacts for People
-
Warning Label Information: The bill would require mifepestrone labels to include a statement claiming that the drug's effects can be counteracted by natural progesterone to increase the chance of fetal survival (Section 2(a)(1)).
-
Access to a Hotline: The bill establishes a toll-free hotline that provides support 24 hours a day, 7 days a week, for women seeking to reverse the effects of mifepristone (Section 2(b)).
Potential Negative Impacts for People
- Limited Hotline Referrals: The bill mandates that any referral made through the newly established hotline may only be made to health care providers that provide abortion pill reversal services (Section 2(b)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make abortion easier to get? — The bill mandates a warning label and restricts hotline referrals to specific abortion pill reversal providers, which may create barriers to medication abortion access.
- Demographic And Interest Groups
- Would women be better off under this? — The bill imposes new requirements on medication labeling and restricts the scope of medical referrals available to women seeking to reverse mifepristone effects.
- Social Issues And Justice
- Does this narrow the gap between how men and women are treated? — By regulating the information and support available to women regarding pregnancy and mifepristone, the bill impacts reproductive autonomy.
- 4/1/2025
- 1 Cosponsor added.
- 2/26/2025
- 1 Cosponsor added.
- 2/6/2025
- 1 Cosponsor added.
- 2/4/2025
- 1 Cosponsor added.
- 1/28/2025
- Referred to the House Committee on Energy and Commerce.
- 9 Cosponsors added.
- Introduced in House
Brian BabinRepublican · Texas
Sheri BiggsRepublican · South Carolina
Andrew ClydeRepublican · Georgia
Andy HarrisRepublican · Maryland
Mark HarrisRepublican · North Carolina
Barry MooreRepublican · Alabama
Riley MooreRepublican · West Virginia
Andrew OglesRepublican · Tennessee
Gary PalmerRepublican · Alabama
John RoseRepublican · Tennessee
Claudia TenneyRepublican · New York
Daniel WebsterRepublican · Florida
Randy WeberRepublican · Texas